We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$414M
AUM Growth
+$26.7M
Cap. Flow
-$16.2M
Cap. Flow %
-3.92%
Top 10 Hldgs %
45.26%
Holding
68
New
4
Increased
5
Reduced
48
Closed
3

Top Buys

Rank Stock Value
1
EFX icon
Equifax
EFX
+$3.8M
2
ULTA icon
Ulta Beauty
ULTA
+$2.62M
3
VVV icon
Valvoline
VVV
+$2.46M
4
RELX icon
RELX
RELX
+$2.1M
5
MRSH
Marsh
MRSH
+$1.11M

Sector Composition

Rank Sector Weight
1 Healthcare 24.3%
2 Technology 20.94%
3 Industrials 17.6%
4 Consumer Staples 13.89%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.81T
$34.3M 8.28%
154,148
-10,930
-7% -$2.35M
MDT icon
2
Medtronic
MDT
$117B
$26M 6.29%
222,301
-11,443
-5% -$1.26M
JNJ icon
3
Johnson & Johnson
JNJ
$646B
$23.9M 5.76%
151,619
-14,704
-9% -$2.17M
MSI icon
4
Motorola Solutions
MSI
$80.4B
$21.8M 5.26%
128,116
-10,271
-7% -$1.72M
UNH icon
5
UnitedHealth
UNH
$353B
$17.9M 4.32%
51,070
-3,506
-6% -$1.18M
MDLZ icon
6
Mondelez International
MDLZ
$79.6B
$15.2M 3.66%
259,601
-9,725
-4% -$556K
CSCO icon
7
Cisco
CSCO
$433B
$13.1M 3.17%
293,249
-4,971
-2% -$204K
BKNG icon
8
Booking.com
BKNG
$155B
$13M 3.15%
146,375
-6,450
-4% -$498K
RTX icon
9
RTX Corp
RTX
$285B
$11.3M 2.73%
158,418
-12,219
-7% -$803K
PM icon
10
Philip Morris
PM
$299B
$10.9M 2.63%
131,785
-4,714
-3% -$367K
BAX icon
11
Baxter International
BAX
$13.5B
$10.5M 2.53%
130,791
+2,940
+2% +$233K
OTIS icon
12
Otis Worldwide
OTIS
$27.3B
$10.1M 2.43%
149,014
-11,570
-7% -$751K
ZBRA icon
13
Zebra Technologies
ZBRA
$16.9B
$9.7M 2.34%
25,246
-2,282
-8% -$768K
AXP icon
14
American Express
AXP
$225B
$8.15M 1.97%
67,375
-4,183
-6% -$463K
CHRW icon
15
C.H. Robinson
CHRW
$17.6B
$7.96M 1.92%
84,836
-5,392
-6% -$514K
MRSH
16
Marsh
MRSH
$91.9B
$7.95M 1.92%
67,936
+9,795
+17% +$1.11M
CTVA icon
17
Corteva
CTVA
$56B
$7.78M 1.88%
201,016
-17,288
-8% -$618K
PEP icon
18
PepsiCo
PEP
$193B
$7.64M 1.84%
51,527
-4,161
-7% -$591K
LHX icon
19
L3Harris
LHX
$48.9B
$7.15M 1.73%
37,831
-2,054
-5% -$376K
PFE icon
20
Pfizer
PFE
$159B
$7.06M 1.7%
191,811
-24,241
-11% -$889K
AON icon
21
Aon
AON
$75.4B
$6.76M 1.63%
32,011
-2,951
-8% -$602K
UNP icon
22
Union Pacific
UNP
$183B
$6.57M 1.59%
31,558
-2,022
-6% -$404K
CPRT icon
23
Copart
CPRT
$30.5B
$6.05M 1.46%
190,084
-15,608
-8% -$455K
AOS icon
24
A.O. Smith
AOS
$8.21B
$5.85M 1.41%
106,634
-6,770
-6% -$373K
LIN icon
25
Linde
LIN
$226B
$5.75M 1.39%
21,826
-1,201
-5% -$295K

Similar funds

Foyston, Gordon, & Payne's Q4 2020 Portfolio in Review

As of Q4 2020, Foyston, Gordon, & Payne held 68 positions worth $414M, up 6.9% from $388M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $16.2M in Q4 2020, closing 3 positions and reducing 48 holdings. Its most notable exit was Check Point Software Technologies, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Equifax worth $4.36M.

  • Foyston, Gordon, & Payne's largest Q4 2020 buy was Equifax: 22,604 shares worth $4.36M.
  • Foyston, Gordon, & Payne added most to Ulta Beauty in Q4 2020, an estimated $2.62M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2020 reduction was Microsoft, cutting an estimated $2.35M.
  • Foyston, Gordon, & Payne fully exited Check Point Software Technologies in Q4 2020, selling an estimated $2.23M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 45% of its $414M portfolio in Q4 2020.
  • Foyston, Gordon, & Payne opened 4 new positions and closed 3 in Q4 2020.
  • Foyston, Gordon, & Payne's portfolio value rose 6.9% quarter-over-quarter to $414M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2020, filed 12 Feb 2021.